title: Complications of lymphadenectomy for gynecologic cancer.
abstract: BACKGROUND
  Symptomatic postoperative lymphocysts (SPOLs) and lower-limb lymphedema (LLL) are probably underestimated complications of lymphadenectomy for gynecologic malignancies. Here, our objective was to evaluate the incidence and risk factors of SPOLs and LLL after pelvic and/or aortocaval lymphadenectomy for gynecologic malignancies.
  
  
  METHODS
  Single-center retrospective study of consecutive patients who underwent pelvic and/or aortocaval lymphadenectomy for ovarian cancer, endometrial cancer, or cervical cancer between January 2007 and November 2008. The incidences of SPOL and LLL were computed with their 95% confidence intervals (95%CIs). Multivariate logistic regression was performed to identify independent risk factors for SPOL and LLL.
  
  
  RESULTS
  We identified 88 patients including 36 with ovarian cancer, 35 with endometrial cancer, and 17 with cervical cancer. The overall incidence of SPOL was 34.5% (95%CI, 25-45) and that of LLL was 11.4% (95% confidence interval [95%CI], 5-18). Endometrial cancer was independently associated with a lower risk of SPOL (adjusted odds ratio [aOR], 0.09; 95%CI, 0.02-0.44) and one or more positive pelvic nodes with a higher risk of SPOL (aOR, 4.4; 95%CI, 1.2-16.3). Multivariate logistic regression failed to identify factors significantly associated with LLL.
  
  
  CONCLUSIONS
  Complications of lymphadenectomy for gynecologic malignancies are common. This finding supports a more restrictive use of lymphadenectomy or the use of less invasive techniques such as sentinel node biopsy.
authors.affiliation: Service de Chirurgie Cancérologique Gynécologique et du Sein, Hôpital Européen Georges Pompidou, AP-HP, Paris, France. abdellaziz.achouri@egp.aphp.fr
authors.forename: A
authors.initials: A
authors.lastname: Achouri
authors.forename: C
authors.initials: C
authors.lastname: Huchon
authors.forename: A S
authors.initials: AS
authors.lastname: Bats
authors.forename: C
authors.initials: C
authors.lastname: Bensaid
authors.forename: C
authors.initials: C
authors.lastname: Nos
authors.forename: F
authors.initials: F
authors.lastname: Lécuru
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000704:Analysis of Variance; D016889:Endometrial Neoplasms / Q000601:surgery; D005260:Female; D005602:France / Q000453:epidemiology; D005833:Genital Neoplasms, Female / Q000473:pathology / Q000601:surgery*; D006801:Humans; D015994:Incidence; D016015:Logistic Models; D035002:Lower Extremity / Q000473:pathology; D008197:Lymph Node Excision / Q000009:adverse effects*; D008198:Lymph Nodes / Q000473:pathology / Q000601:surgery; D008209:Lymphedema / Q000453:epidemiology* / Q000209:etiology*; D008210:Lymphocele / Q000453:epidemiology* / Q000209:etiology*; D008875:Middle Aged; D015999:Multivariate Analysis; D016017:Odds Ratio; D010051:Ovarian Neoplasms / Q000601:surgery; D012189:Retrospective Studies; D012307:Risk Factors; D002583:Uterine Cervical Neoplasms / Q000601:surgery